Nelson Wang

Nelson Wang edits the technology and health care stocks coverage at TheStreet. Prior to TheStreet, he was the business and personal finance editor for Yahoo!'s home page, and he's also worked as an editor at Condé Nast Portfolio, CBS MoneyWatch, Internet World and aMedia. Nelson has a bachelor's degree in Social Studies from Harvard College. 

Recent Articles By The Author

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

The two corporate moguls are going head-to-head over Twenty-First Century Fox's valuable entertainment assets.

Instagram Launches New Longform Video Platform

Instagram Launches New Longform Video Platform

The new platform could become a serious rival to Google's YouTube.

Listen: The AT&T Time Warner Ruling and Its Impact on M&A

Listen: The AT&T Time Warner Ruling and Its Impact on M&A

The Deal's senior editor in Washington, D.C. David Hatch and senior writer Chris Nolter break down what the ruling does and doesn't mean for future deals.

Listen: How Golden Is Apple's Future?

Listen: How Golden Is Apple's Future?

The tech giant is now within striking distance of becoming the first company to reach a trillion-dollar valuation. Will recent software announcements help get it there soon?

Apple Is the Favorite to Reach $1 Trillion Market Cap First, but Rivals Loom

Apple Is the Favorite to Reach $1 Trillion Market Cap First, but Rivals Loom

As Apple gets within striking distance of the whopping valuation, here's what share price each of its top rivals needs to reach to keep pace.

Activist Investors Discuss Deals; Markets Await G-7 Meeting -- ICYMI

Activist Investors Discuss Deals; Markets Await G-7 Meeting -- ICYMI

Here's what you need to know now for Thursday, June 7.

Listen: WSJ's John Carreyrou on the Theranos Fraud and How It Happened

Listen: WSJ's John Carreyrou on the Theranos Fraud and How It Happened

The massive fraud perpetuated by blood-testing start-up Theranos could not have happened without the lines between traditional technology VC and health care VC blurring. The WSJ reporter who first exposed the fraud explains what happened.

Tesla's Model 3 Is Far From Being for the Masses -- at Least For Now

Tesla's Model 3 Is Far From Being for the Masses -- at Least For Now

Customers looking to take delivery of the least expensive $35,000 version of the Model 3 have some waiting ahead of them.

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

The networking giant beat quarterly earnings and sales expectations, but not by enough to excite investors. Now that its stock has been clipped, is it a good time to get in? Listen to TheStreet's latest episode of Technically Speaking with Nelson Wang.

Listen: Where Does Nvidia's Stock Go From Here?

Listen: Where Does Nvidia's Stock Go From Here?

The red-hot chipmaker just reported another extremely strong quarter of earnings, but also warned about a significant drop in sales to cryptocurrency miners next quarter, causing its stock to decline.